LG Chem: Accelerating the development of high-potential anti-cancer drugs with AI technology.

On June 18th, LG Chem announced a partnership with the British company LabGenius Therapeutics, signing a joint research and option agreement for the development of multiple antibody anti-cancer drug candidates. LG Chem will pay LabGenius upfront payment and research fees. In the future, both parties will decide whether to exercise subsequent development and licensing based on the joint research results.